Back
Dermata Therapeutics Quote, Financials, Valuation and Earnings
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
17
DRMA
Dermata Therapeutics
Last Price:
1.92
Seasonality Move:
-51.46%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock marketDermata Therapeutics Price Quote
$1.92
-0.33 (-14.67%)
(Updated: September 19, 2024 at 12:55 PM ET)
Dermata Therapeutics Key Stats
Sell
17
Dermata Therapeutics (DRMA)
is a Sell
Day range:
$1.93 - $2.38
52-week range:
$1.29 - $17.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.89%
Volume:
580.6K
Avg. volume:
961.6K
1-year change:
-87.07%
Market cap:
$3M
Revenue:
$0
EPS:
$-27.47
How Much Does Dermata Therapeutics Make?
Data Unavailable
Is Dermata Therapeutics Growing As A Company?
Data Unavailable
Dermata Therapeutics Stock Price Performance
-
Did Dermata Therapeutics Stock Go Up Last Month?
Dermata Therapeutics share price went up by 14.8% last month -
Did DRMA's Share Price Rise Over The Last Year?
DRMA share price fell by -87.07% over the past 1 year
What Is Dermata Therapeutics 52-Week High & Low?
-
What Is Dermata Therapeutics’s 52-Week High Share Price?
Dermata Therapeutics has traded as high as $17.25 over the past 52 weeks -
What Is Dermata Therapeutics’s 52-Week Low Share Price?
Dermata Therapeutics has traded as low as $1.29 over the past 52 weeks
Dermata Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Dermata Therapeutics?
-
How Much Debt Does Dermata Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Dermata Therapeutics Have?
Cash and short term investments quarterly total is $4.9M -
What Is Dermata Therapeutics’s Book Value Per Share?
Book value per share is 4.79
Is Dermata Therapeutics Cash Flow Positive?
-
What Is DRMA Cash Flow From Operations?
Cash flow from operations (TTM) is -$7.7M -
What Is Dermata Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $4.3M -
What Is Dermata Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Dermata Therapeutics Return On Invested Capital
Data Unavailable
Dermata Therapeutics Earnings Date & Stock Price
-
What Is Dermata Therapeutics's Stock Price Today?
A single share of DRMA can be purchased today for 2.25 -
What Is Dermata Therapeutics’s Stock Symbol?
Dermata Therapeutics trades on the nasdaq under the ticker symbol: DRMA -
When Is Dermata Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Dermata Therapeutics is scheduled on September 19, 2024 -
When Is DRMA's next ex-dividend date?
Dermata Therapeutics's next ex-dividend date is September 19, 2024 -
How To Buy Dermata Therapeutics Stock?
You can buy Dermata Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Dermata Therapeutics Competitors
-
Who Are Dermata Therapeutics's Competitors?
Below is a list of companies who compete with Dermata Therapeutics or are related in some way:
Dermata Therapeutics Dividend Yield
-
What Is DRMA Dividend Yield?
Dermata Therapeutics’s dividend yield currently is 0% -
What Is Dermata Therapeutics’s Payout Ratio?
Dermata Therapeutics’s payout ratio is 0% -
When Did Dermata Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is Dermata Therapeutics’s Dividend Per Share?
Dermata Therapeutics pays a dividend of $0.00 per share
Dermata Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 6.00 |
| Upside from Last Price: | 166.67% |